Frontispiece: A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors

Immunotherapeutic Agents. A NIR-light-activated and lysosomal-targeted PtII metallacycle for evoking of immunogenic cell death that potentiates cancer immunotherapy of deep-seated tumors is reported by Peter J. Stang, Yan Sun, Yao Sun et al. in their Research Article (e202406392).